A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
St. Jude Children's Research Hospital
Centre Hospitalier Universitaire de Liege
Washington University School of Medicine
Fundació Sant Joan de Déu
Amsterdam UMC, location VUmc
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Duke University
Sun Yat-sen University
Ann & Robert H Lurie Children's Hospital of Chicago
Emory University
Emory University
St. Jude Children's Research Hospital
Children's Oncology Group
Istanbul University - Cerrahpasa
St. Jude Children's Research Hospital
Wills Eye
Fondation Ophtalmologique Adolphe de Rothschild
Charite University, Berlin, Germany
Memorial Sloan Kettering Cancer Center
Laboratorio Elea Phoenix S.A.
National Cancer Institute (NCI)
Sun Yat-sen University
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Weill Medical College of Cornell University
Pediatric Brain Tumor Consortium
Samsung Medical Center
Memorial Sloan Kettering Cancer Center
Hospital JP Garrahan